Table 2.
Hazard ratios and 95% confidence intervals for univariable and multivariable associations between IHC4-score and breast cancer subtypes (luminal B-like vs. A-like) with 10-year breast cancer-specific survival among women in the Polish and SEARCH study populations and in both studies combined
Polish study | SEARCH study | Combined | |||||||
---|---|---|---|---|---|---|---|---|---|
Parameter | Hazard ratio | P-value | LR χ2 | Hazard ratio | P-value | LR χ2 | Hazard ratio | P-value | LR χ2 |
Univariable analysis | |||||||||
Subtype (luminal B-like vs. A-like) | 1.75 (0.88–3.48) | 0.11 | 2.8 | 1.65 (1.23–2.21) | 0.001 | 10.9 | 1.64 (1.25–2.14) | <0.001 | 23.4 |
IHC4-score/1 standard deviation | 1.54 (1.27–1.81) | <0.001 | 13.7 | 1.28 (1.15–1.41) | <0.001 | 18.2 | 1.32 (1.20–1.44) | <0.001 | 40.1 |
C-score /1 standard deviation | 1.73 (1.45–2.02) | <0.001 | 23.9 | 1.79 (1.67–1.92) | <0.001 | 137.9 | 1.78 (1.67–1.90) | <0.001 | 168.2 |
PREDICT-score/1 standard deviation | 2.21 (1.67–2.93) | <0.001 | 27.9 | 2.41 (2.10–2.77) | <0.001 | 144.7 | 2.34 (2.07–2.65) | <0.001 | 178.5 |
Multivariable analysisa | |||||||||
IHC4-score/1 standard deviation | 1.46 (1.18–1.74) | 0.001 | 9.8 | 1.25 (1.11–1.39) | <0.001 | 12.0 | 1.29 (1.16–1.42) | <0.001 | 19.1 |
C-score/1 standard deviation | 1.62 (1.31–1.93) | <0.001 | 14.5 | 1.78 (1.65–1.91) | <0.001 | 129.1 | 1.75 (1.63–1.87) | <0.001 | 140.1 |
Multivariable analysisb | |||||||||
IHC4-score/1 standard deviation | 1.46 (1.17–1.74) | 0.002 | 9.2 | 1.19 (1.05–1.33) | 0.007 | 7.0 | 1.24 (1.11–1.37) | <0.001 | 12.5 |
PREDICT-score/1 standard deviation | 1.91 (1.43–2.56) | <0.001 | 17.1 | 2.40 (2.09–2.77) | <0.001 | 135.7 | 2.26 (1.99–2.56) | <0.001 | 147.1 |
Multivariable analysisc | |||||||||
Subtype (luminal B-like vs. A-like) | 1.24 (0.58–2.62) | 0.58 | 0.3 | 1.51 (1.08–2.12) | 0.02 | 5.7 | 1.38 (1.02–1.88) | 0.04 | 4.3 |
PREDICT-score/1 standard deviation | 1.94 (1.44–2.76) | <0.001 | 17.6 | 2.48 (2.13–2.88) | <0.001 | 125.1 | 2.30 (2.01–2.63) | <0.001 | 136.5 |
Multivariable (luminal A-like tumors only) | |||||||||
IHC4-score/1 standard deviation | 1.29 (0.69–1.90) | 0.34 | 0.9 | 1.15 (0.93–1.40) | 0.17 | 1.9 | 1.20 (0.98–1.43) | 0.07 | 3.1 |
PREDICT-score/1 standard deviation | 1.32 (0.57–3.07) | 0.51 | 3.7 | 2.33 (1.87–2.90) | <0.001 | 52.1 | 2.14 (1.74–2.64) | <0.001 | 46.1 |
Multivariable (luminal B-like tumors only) | |||||||||
IHC4-score/1 standard deviation | 1.48 (1.14–1.82) | 0.006 | 6.9 | 1.14 (0.92–1.36) | 0.20 | 1.6 | 1.22 (1.03–1.41) | 0.01 | 5.3 |
PREDICT-score/1 standard deviation | 2.21 (1.56–3.12) | <0.001 | 18.5 | 2.59 (2.06–3.26) | <0.001 | 65.7 | 2.36 (1.96–2.84) | <0.001 | 80.4 |
aHazard ratio was mutually adjusted for IHC4-score, C-score, age, treatment, and, in the combined model, study
bHazard ratio was mutually adjusted for IHC4-score, age, PREDICT-score (which combines information on lymph-nodal involvement, histologic grade, patient age, tumor size, and mode of detection—because we did not have data on mode of detection, this was not computed), treatment and, in the combined model, study
cHazard ratio was mutually adjusted for subtype, age, PREDICT-score, treatment and, in the combined model, study. LRχ2 = likelihood ratio chi-square